Detalhe da pesquisa
1.
The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions.
Nat Immunol
; 15(5): 431-8, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24658051
2.
Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells.
Nat Immunol
; 13(12): 1171-7, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23142773
3.
Cutting edge: DNAX accessory molecule 1-deficient CD8+ T cells display immunological synapse defects that impair antitumor immunity.
J Immunol
; 192(2): 553-7, 2014 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24337740
4.
Promoting regulation via the inhibition of DNAM-1 after transplantation.
Blood
; 121(17): 3511-20, 2013 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23430112
5.
DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases.
J Immunol
; 184(2): 902-11, 2010 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20008292
6.
The interactions of multiple cytokines control NK cell maturation.
J Immunol
; 185(11): 6679-88, 2010 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20974986
7.
Mesothelial fusion mediates chorioallantoic membrane formation.
Philos Trans R Soc Lond B Biol Sci
; 377(1865): 20210263, 2022 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36252211
8.
The mTORC1 inhibitor everolimus prevents and treats Eµ-Myc lymphoma by restoring oncogene-induced senescence.
Cancer Discov
; 3(1): 82-95, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23242809
9.
Receptors that interact with nectin and nectin-like proteins in the immunosurveillance and immunotherapy of cancer.
Curr Opin Immunol
; 24(2): 246-51, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22285893
10.
An immunosurveillance mechanism controls cancer cell ploidy.
Science
; 337(6102): 1678-84, 2012 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23019653
11.
Poker face no more: cancer recurrence reveals its hand.
Nat Med
; 19(12): 1569-70, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24309652
12.
Can NK cells be a therapeutic target in human cancer?
Eur J Immunol
; 38(11): 2964-8, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18979512
13.
DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors.
J Exp Med
; 205(13): 2965-73, 2008 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-19029380